Calls for papers
-
A new animation from Copley Scientific shows how the standard compendial set-up for cascade impaction can be enhanced to ensure that data generated in the lab (in vitro) is as representative as possible of what… Read more . . .
-
The 27th Drug Delivery to the Lungs (DDL) meeting expects a record number of delegates and exhibitors when the meeting returns to the Edinburgh International Conference Centre December 7-9. And, organizers say, being able to… Read more . . .
-
Windtree Therapeutics has announced that a lung deposition study in cynomolgus macaques showed that its proprietary aerosol delivery system (ADS) delivered KL4 surfactant uniformly to all regions of the lung. The ADS is being developed… Read more . . .
-
Eurocine Vaccines has started a Phase 1/2 clinical study of its Immunose FLU intranasal quadrivalent influenza vaccine, which uses the company’s Endocine adjuvent and inactivated split antigens, the company said. Results should be available in… Read more . . .
-
The FDA’s Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) has voted to recommend approval of Allergan’s SER120 desmopressin nasal spray for the treatment of nocturia (needing to wake up to urinate at night) in… Read more . . .
-
The US Patent and Trademark Office (USPTO) has granted SmartInhaler maker Adherium Limited US Patent No. 9,468,729, titled “Releasable monitor with optical dose counter for a medicament inhaler, the company announced, saying that, “This patent… Read more . . .
-
Sunovion Pharmaceuticals and the American College of Chest Physicians (CHEST) have launched an initiative called “Delivery Makes a Difference,” which they say “seeks to understand patient and health care provider practices and to provide tools… Read more . . .
-
PPD has added 4,300 sq ft to its GMP biopharmaceuticals and inhalation facility in Athlone, Ireland, the company has announced. The facility, which opened in 2010 and offers a wide range of formulation, development, and… Read more . . .
-
Theravance Biopharma and Mylan have announced that two 12-week Phase 3 efficacy studies of nebulized revefenacin (TD-4208) for the treatment of COPD have met their primary efficacy endpoint of statistically significant increase in FEV1 for… Read more . . .
-
Propeller Health has closed on a $21.5 million Series C funding round to support expansion of its digital inhaler monitoring platform, the company said. Investors included 3M Ventures, S.R. One, Limited and Hikma Ventures, Safeguard… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland